Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

INTRODUCTION: Most breast cancers that occur in women with germline BRCA1 mutations are estrogen receptor-negative (ER-) and also typically lack expression of progesterone receptor (PR) and HER2 overexpression. We undertook a study to assess the clinical factors that predict for an estrogen receptor...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tung, Nadine, Wang, Yihong, Collins, Laura C, Kaplan, Jennifer, Li, Hailun, Gelman, Rebecca, Comander, Amy H, Gallagher, Bridget, Fetten, Katharina, Krag, Karen, Stoeckert, Kathryn A, Legare, Robert D, Sgroi, Dennis, Ryan, Paula D, Garber, Judy E, Schnitt, Stuart J
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880433/
https://ncbi.nlm.nih.gov/pubmed/20149218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2478
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky